Related Experiment Video
Updated: May 11, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Enteroviral myocarditis in neonates
Luregn J Schlapbach1, Joerg Ersch, Christian Balmer
1Paediatric Intensive Care Unit, Mater Children's Hospital, Brisbane, Queensland, Australia.
Insights
Neonatal myocarditis caused by enteroviruses can be fatal. Extracorporeal membrane oxygenation (ECMO) may be life-saving for infants with severe cardiorespiratory failure, but outcomes vary.
Area of Science:
- Pediatrics
- Infectious Diseases
- Cardiology
Background:
- Enteroviruses are common pediatric viral pathogens.
- While typically causing mild illness, enteroviruses can lead to severe conditions like myocarditis in neonates.
- Neonatal myocarditis presents a significant mortality risk.
Observation:
- Two cases of neonatal enteroviral myocarditis are presented.
- Both infants experienced cardiorespiratory failure and severe shock unresponsive to standard treatments.
- Extracorporeal membrane oxygenation (ECMO) was required for hemodynamic support.
Findings:
- One neonate with Coxsackievirus B3 myocarditis died after 3 weeks on ECMO.
- The second neonate, supported with ECMO for 9 days, recovered completely after decannulation.
- Neonatal myocarditis demonstrates a high mortality rate.
Implications:
- Early consideration of ECMO is crucial for neonates with enteroviral myocarditis experiencing rapid clinical and echocardiographic decline.
- Aggressive supportive care, including ECMO, may improve outcomes in severe cases.
- Further research into the management of neonatal enteroviral myocarditis is warranted.
Abstract:
Enteroviruses are a leading cause of viral infections in children. While most enteroviral infections are mild and self-limiting, severe disease such as a viral sepsis syndrome, myocarditis, hepatitis and meningoencephalitis may occur. We present two cases of neonatal enteroviral myocarditis. Cardiorespiratory failure occurred in both cases, and severe shock refractory to conventional treatment required support with extracorporeal membrane oxygenation (ECMO). One child with coxsackievirus B3 myocarditis failed to recover and died after 3 weeks on ECMO, while one child could be decannulated successfully after 9 days of ECMO and recovered completely subsequently. In conclusion, neonatal myocarditis has a very high mortality, and ECMO should be considered early in neonates with rapid clinical and echocardiographic deterioration despite adequate inotropic support.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Cytomegalovirus Disease
Myocarditis II: Clinical Features and Diagnostic Tests
Viral Meningitis
Myocarditis IV: Nursing Management

